TCL Archive ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard September 13, 2002
TCL Archive In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial April 29, 1988
TCL Archive Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency. December 19, 2008
TCL Archive Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach February 7, 2014
TCL Archive Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer February 25, 2011
